Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has approved High Definition Breast Tomosynthesis. This unique form of digital breast tomosynthesis (DBT) includes new algorithms designed to deliver a heightened level of sensitivity to breast cancer detection and diagnosis over 2-D mammography alone.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now